Effect of fish oil concentrate on lipoprotein composition in NIDDM
- 1 November 1988
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 37 (11) , 1567-1573
- https://doi.org/10.2337/diabetes.37.11.1567
Abstract
Non-insulin-dependent diabetes mellitus (NIDDM) is associated with elevated very-low-density lipoprotein (VLDL) triglyceride concentrations and abnormalities of low-density lipoprotein (LDL) composition. Because fish oil supplementation may favorably affect lipid and lipoprotein concentrations in nondiabetic subjects, we determined the effect of fish oil concentrate on plasma lipids and lipoprotein composition in patients with NIDDM. Dietary-supplementation 1-mo periods of 4.0 and 7.5 g of omega-3 fatty acids in fish oil were compared with a placebo of 12 g safflower oil by use of a single-blind crossover design. Medications, including antidiabetic therapy, were continued through the study. Compared with safflower oil treatment, fish oil supplementation resulted in a significant reduction of total plasma triglycerides of 24% at the 4-g doseand a larger reduction of 39% at the 7.5-g dose. These decreases were due to similar reductions in VLDL triglycerides. LDL cholesterol levels were mildly elevated, but a larger 20% increase in LDL apolipoprotein B (apoB) concentration was observed. During supplementation with the fish oil concentrate, the LDL cholesterol-to-apoB ratio was significantly reduced when compared with pretreatment values, but not when compared with safflower oil treatment. Highdensity lipoprotein (HDL) cholesterol and plasma apoA1 levels were not significantly changed during fish oil treatment. At the 7.5-g dose, fasting glucose and glycohemoglobin levels increased by 20 and 12%, respectively, but were unchanged at the lower level of supplementation. Thus, in NIDDM patients, dietary supplementation with omega-3 fatty acids induces a reduction in total plasma and VLDL triglyceride levels. However, the observed increase in LDL apoB levels, and the deterioration in glycemic control, indicate thatfurther study will be required to establish whether fish oil has a role in the treatment of NIDDM.This publication has 27 references indexed in Scilit:
- Lipoxygenase Pathway in Islet Endocrine Cells. OXIDATIVE METABOLISM OF ARACHIDONIC ACID PROMOTES INSULIN RELEASEJournal of Clinical Investigation, 1983
- The Effect of N-6 and N-3 Polyunsaturated Fatty Acids on Hemostasis, Blood Lipids and Blood PressureThrombosis and Haemostasis, 1983
- Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1983
- The comparative reductions of the plasma lipids and lipoproteins by dietary polyunsaturated fats: Salmon oil versus vegetable oilsMetabolism, 1983
- The Influence of Different Types of ω3 Polyunsaturated Fatty Acids on Blood Lipids and Platelet Function in Healthy VolunteersClinical Science, 1983
- Association of Hyperapobetalipoproteinemia with Endogenous Hypertriglyceridemia and AtherosclerosisAnnals of Internal Medicine, 1982
- Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].Proceedings of the National Academy of Sciences, 1980
- ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?The Lancet, 1979
- Determination of the Glycosylated Hemoglobins (Hb AI) with a New Microcolumn Procedure: Suitability of the Technique for Assessing the Clinical Management of Diabetes MellitusDiabetes, 1978
- MATHEMATICAL EVALUATION OF METHODS FOR ESTIMATION OF CONCENTRATION OF MAJOR LIPID COMPONENTS OF HUMAN-SERUM LIPOPROTEINS1976